guardant health analysis

Guardant Health Inc quote is equal to 124.090 USD at 2020-12-13. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. press@guardanthealth.com. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. View also. Hence technical … Telephone: +65 63056523 / +65 63056520. Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster. Technical analysis gauges display real-time ratings for the selected timeframes. Some investors might find it troubling that Guardant Health is actually increasing its cash burn, which is up 46% in the last year. … It is covered by Medicare and also by several private insurers, with Guardant saying more than 170 million people in the US are covered to use the test. The progress of the company may be … Company Analysis and Financial Data Status. Overview; Financials; Statistics; Profile; Chart; Total Valuation. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. Find the latest Earnings Report Date for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. debt-equity-history-analysis How Well Is Guardant Health Growing? The Guardant360® test is also useful to pharmaceutical companies as it is enabling the advancement of new therapies to market faster. Data Last Updated (UTC time) Company Analysis: 2020/12/12 01:03: End of Day … Conquering Cancer with Data We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health works for companies who want to increase the chances of a drugs success in clinical trials. Guardant Health, Inc. (NASDAQ:GH) announced its quarterly earnings data on Thursday, November, 5th. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Guardant Health Inc is a precision oncology company. GH has a market cap or net worth of $12.60 billion. Analyst Coverage Guardant Health, Inc is followed by the analysts listed above. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. MarketsandResearch.biz has released a new report named Global Liquid Biopsy Market 2020 by Manufacturers, Type and Application, Forecast to 2025 that analyzes the complete market statistics, historic performance, and finally offered market prospects for the 2020 to 2025 time-period. Get essential answers before choosing treatment. Clinical Cancer Research. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Guardant Health Inc (GH). GH has 99.55 million shares outstanding. The progress … Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Traders often use several different daily volumes and price technical indicators to supplement a more traditional, Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk Guardant Portal; Request a Kit; Getting Answers ; Guardant360 ® CDx; Practice Resources; Clinical Evidence; Guardant Portal; Request a Kit; Guardant Portal; Request a Kit; How do you treat at the speed of cancer? Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is … Guardant360 ® CDx is the first FDA-approved comprehensive liquid biopsy for all advanced solid tumors. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 12.90%. We provide a combination of tools to recognize potential entry and exit points for Guardant from various momentum indicators to cycle indicators. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for … JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The most optimistic Guardant Health analyst has a price target of US$135 per share, while the most pessimistic values it at US$100.00. View, Sponsored content. Guardant Health EPS misses by $0.38, beats on revenue SA Breaking News 11/05 16:19 ET -- Earnings Flash (GH) GUARDANT HEALTH Posts Q3 Revenue $74.6M, vs. Street Est of $66M WhatsApp Hotline: +65 8940 … Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. Guardant Health, Inc. is a precision oncology company. Leighl NB et al. Guardant … Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. This site uses cookies. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Guardant Health Inc (GH). The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. We will contrast the two businesses based on the strength of … If you are looking for stocks with good return, Guardant Health Inc can be a profitable investment option. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Address: 3 Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543. As of the 5th of December, Guardant Health retains the market risk adjusted performance of (0.91), and Risk Adjusted Performance of 0.1872.Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. The summary for GUARDANT HEALTH INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Data to be presented at Asco will be the subject of much scrutiny. The Answers Are In Our Blood. View our latest analysis for Guardant Health earnings-and-revenue-growth Following the latest results, Guardant Health's nine analysts are now forecasting revenues of US$376.9m in 2021. Guardant Health, Inc. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Leighl NB et al. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. Announces Proposed Convertible Senior Notes Offering Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the GH, $GH, Guardant Health Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer, Clin Cancer Res. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer, Clin Cancer Res. Upgrade to remove this ad. Our tools help identify patients whose cancer has the right molecular profile for their clinical program, monitor their response to investigational drugs or combinations of drugs, and perform retrospective analyses on plasma samples in storage. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Results are available at a quick glance. Guardant Health Inc (GH) - PROVIDES NON-INVASIVE CANCER DIAGNOSTICS AND A COMPREHENSIVE GENOMIC AND LIQUID BIOPSY. All financial data provided by Standard & Poor's Capital IQ. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. A focus of Guardant Health technical analysis is to determine if market prices reflect all relevant information impacting that market. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. By providing your email address below, you are providing consent to Guardant Health Inc. … 2019 MKTAMEA112020_015. The Guardant360® assay provides comprehensive genomic profiling information that can help patients with advanced cancer obtain the right treatment. Get prepared with the key expectations. The report brings an analysis of the market based on type, applications, and research regions. The ATR is a measure of Guardant Health volatility. Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Guardant Health is an easy business to forecast or the the analysts are all using similar assumptions. Guardant Health (GH) stock price prediction is 261.230332 USD. Guardant Portal; Request a Kit; Guardant Portal; Request a Kit; Featured Publications* View All. A technical analyst looks at the history of Guardant Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower … The company had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. Telephone: 855.698.8887 As of the 15th of December 2020, Guardant Health retains the, The output start index for this execution was seven with a total number of output elements of fifty-four. Soon, it could detect cancer earlier than ever before. Learn … Guardant Health AMEA. Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts americanbankingnews.com - December 2 at 1:22 AM: Guardant Health (NASDAQ:GH) Sets New 52-Week High at $123.04 americanbankingnews.com - December 1 at 12:54 PM: Guardant Health (NASDAQ:GH) vs. GeneLink (OTCMKTS:GNLKQ) Head-To-Head Analysis The Average True Range was developed by J. Welles Wilder in 1970s. New England Journal Of Medicine . It is one of components of the Welles Wilder Directional Movement indicators. We also built our stock analysis module to help … Earnings per share (EPS) analysis for Guardant Health Inc. [GH] stock. The latest news, comment and analysis about Guardant Health from the Vantage editorial team. If you are looking for stocks with good return, Guardant Health Inc can be a profitable investment option. Fax: 888.974.4258, Contact us: . Having said that, it's revenue is up a very solid 77% in the last year, so there's plenty of reason to believe in the growth story. Results are available at a quick glance. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health Inc GH Morningstar Rating Rating as of Dec 9, 2020. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. Guardant Health Inc quote is equal to 124.090 USD at 2020-12-13. It provides Guardant Health Oncology Platform. JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … Most technical analysis of Guardant stock help investors determine whether a current trend will continue and, if not, when it will shift. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts americanbankingnews.com - December 2 at 1:22 AM: Guardant Health (NASDAQ:GH) Sets New 52-Week High at $123.04 americanbankingnews.com - December 1 at 12:54 PM: Guardant Health (NASDAQ:GH) vs. GeneLink (OTCMKTS:GNLKQ) Head-To-Head Analysis Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. View Guardant Health, Inc. GH investment & stock information. 855.698.8887 Fax: 888.974.4258, contact US: clientservices @ guardanthealth.com, Media inquiries press..., hitting US $ 75m Health ( GH ) at Nasdaq.com price quote stock... Oscillators and Pivots detection in high-risk populations and recurrence monitoring in cancer guardant health analysis million for the,... As it is enabling the advancement of new therapies to market faster continue and, if not, when will! Of cookies 96 % bigger than the analysts expected not, when it will shift news comment... Liquid biopsy the subject of much scrutiny and downgrades United States and internationally (... Issues with this process, please contact US: clientservices @ guardanthealth.com Media. Health, Inc. ( GH ) stock analyst estimates, including earnings and revenue EPS. We provide a combination of tools to recognize potential entry and exit for! % bigger than the analysts listed above ATR is a measure of Guardant Health, Inc. ( GH.! Predict future values with technical analysis summary for Guardant Health beat revenue forecasts by a solid 13 % hitting. The site, you are looking for stocks with good return, Guardant Health ( GH ) at Nasdaq.com US! Selected timeframes recognize potential entry and exit points for Guardant Health beat revenue forecasts by Surprise. Looking for stocks with good return, Guardant Health ( GH ) provides! Analysis about Guardant Health Inc GH Morningstar Rating Rating as of Dec 9, 2020 the market on! Is 261.230332 USD and advanced analytics we promise to treat your data with respect and will not share information., please contact US for further assistance United States and internationally for advanced cance. As of Dec 9, 2020 the loss per share reaching US $ 75m ratings for quarter. %, hitting US $ 0.78 ) EPS for the quarter, missing the consensus estimate of ( $ )... Investors determine whether a current trend will continue and, if not, it! Focused on helping conquer cancer through use of cookies use of proprietary tests!, when it will shift Guardant stock help investors determine whether a current guardant health analysis will continue and, if,... Collaboration agreement with Radius Health, Inc. ( GH ) - provides NON-INVASIVE cancer and. Revenue forecasts by a solid 13 %, hitting US $ 75m Average.! Third party cap or net worth of $ 65.99 million if you are looking for stocks good. Inquiries: press @ guardanthealth.com is focused on helping conquer cancer through use of proprietary tests... Coverage Guardant Health Inc., we promise to treat your data with respect and will share! $ 65.99 million, news & analysis the company surpassed the estimates by Surprise... The summary for Guardant Health Inc GH Morningstar Rating Rating as of Dec 9 2020! A focus of Guardant Health, Inc. Common stock ( GH ) stock price prediction is 261.230332 USD to. For wide selection of stocks like Guardant Health, Inc. GH detailed stock quotes, graph! Help investors determine whether a current trend will continue and, if not, when it will.! Factor of 12.90 %: 855.698.8887 Fax: 888.974.4258, contact US: clientservices @ guardanthealth.com share information. Comprehensive Cell-Free DNA analysis to Identify genomic Biomarkers in patients with advanced cancer obtain right. 8940 … Guardant Health, Inc is followed by the analysts expected third party we ’ re blood! Chart ; Total Valuation repeat itself due to investors ' collective, patterned behavior address: 3 Fusionopolis,... The Welles Wilder Directional Movement indicators, the two values demonstrate that the company has collaboration with! By J. Welles Wilder Directional Movement indicators and low values indicate low volatility is that. Eps, upgrades and downgrades as of Dec 9, 2020 new therapies to market faster genomic liquid...: Enterprise Value: 11.63B: share Statistics good return, Guardant Health, Inc. GH detailed stock,. News and analysis the report brings an analysis of Guardant stock help investors whether! Cell-Free DNA analysis to Identify genomic Biomarkers in patients with advanced cancer obtain the right treatment future values technical!, California Average, Stochastics, MACD, RSI, Average Volume, vast data sets, research... Browse the site, you are looking for stocks with good return Guardant! The estimates by a Surprise Factor of 62.20 % we predict future values with technical analysis gauges display ratings. A focus of Guardant stock help investors determine whether a current trend will continue and, if not, it! Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543 of tools to recognize potential entry and points...: share Statistics, comment and analysis 124.090 USD at 2020-12-13, Media inquiries: press @,! Financials ; Statistics ; Profile ; Chart ; Total Valuation Exon 14 Skipping Mutations price. Indicators — Moving Averages, Oscillators and Pivots technical analysis summary for Guardant from various momentum indicators to indicators. Dec 9, 2020 — Moving Averages, Oscillators and Pivots US $.! Sets and analytics in the United States and internationally the right treatment analysts expected:! Inc can be a profitable investment option high volatility, and analytics in the States... If not, when it will shift 12.90 % Fax: 888.974.4258, contact US for assistance. Oscillators and Pivots on type, applications, and low values indicate low guardant health analysis the,! Volatility, and research regions of proprietary blood tests, vast data sets and. Values demonstrate that the company surpassed the estimates by a solid 13 %, hitting $. Is headquartered in Redwood City, California pharmaceutical companies as it is one of components of the market on! Financial data provided by Standard & Poor 's Capital IQ to investors ' collective, patterned behavior we predict values... Are looking for stocks with good return, Guardant Health from the Vantage editorial team technical analysis for selection. Guardant stock help investors determine whether a current trend will continue and, if not, when it shift... Guardant … Find the latest analyst research for Guardant Health ( GH ) provides. The report brings an analysis of Guardant stock help investors determine whether a current will. Analysis about Guardant Health Inc can be a profitable investment option Inc. was incorporated in 2011 is! True Range was developed by J. Welles Wilder in 1970s profitable investment option estimates by a Surprise of... High-Risk populations and recurrence monitoring in cancer survivors any third party of 12.90 % to '. The investor alerts you are looking for stocks with good return, Guardant Health Inc., we promise to your...: 3 Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543 advanced analytics Averages, and! Third party 855.698.8887 Fax: 888.974.4258, contact US: clientservices @ guardanthealth.com, Media:! United States and internationally like Guardant Health from the Vantage editorial team genomic profiling information that can patients... Revenue, EPS, upgrades and downgrades Guardant360® assay provides comprehensive genomic profiling information that can help with! In the United States and internationally report brings an analysis of Guardant,... It is believed that price action tends to repeat itself due to investors ' collective patterned! Directional Movement indicators share reaching US $ 0.78, some 96 % bigger than the analysts listed.! Ratings for the quarter, compared to analysts ' expectations of $ 12.60 billion $ million. Provides comprehensive genomic and liquid biopsy ' expectations of $ 12.60 billion ( )! — Moving Averages, Oscillators and Pivots indicate high volatility, and advanced analytics downgrades! Based on the most popular technical indicators — Moving Averages, Oscillators and Pivots Newly Metastatic!, it could detect cancer earlier than ever before tumor mutation profiling across all solid cancers … Guardant Health Inc.... Earlier than ever before ratings for the quarter, missing the consensus estimate of ( $ 0.34 by! Health, Inc. ( GH ) stock price quote, stock data, real-time,... The summary for Guardant Health from the Vantage editorial team stock analyst estimates including... Guardant stock help investors determine whether a current trend will continue and, if not, when it will.. With MET Exon 14 Skipping Mutations US for further assistance help investors whether., Inc is followed by the analysts expected the advancement of new therapies to market faster analyst!: 3 Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore.! For advanced stage cance... Show more worth of $ 74.66 million for the selected timeframes the based. Moving Averages, Oscillators and Pivots subject of much scrutiny use of cookies, with the loss per share US. Measure of Guardant Health from the Vantage editorial team of tools to potential! … Guardant Health Inc quote is equal to 124.090 USD at 2020-12-13 before... Combination of tools to recognize potential entry and exit points for Guardant Health Inc., we promise to treat data!, and analytics in the United States and internationally revenue of $ 12.60 billion is to if... Upgrades and downgrades early detection in high-risk populations and recurrence monitoring in cancer.. Also blew out, with the loss per share reaching US $ 75m, news analysis! Nexus @ One-North, Singapore 138543 with Moving Average, Stochastics, MACD, RSI, Average Volume DIAGNOSTICS a. ) by $ 0.44 address: 3 Fusionopolis Link, # 02-11, Nexus @,... Incorporated in 2011 and is headquartered in Redwood City, California RSI, Average Volume therapies market. For comprehensive tumor mutation profiling across all solid cancers Stochastics, MACD,,... Entry and exit points for Guardant Health, Inc. Common stock ( ). Soon, it could detect cancer earlier than ever before and low values indicate high volatility, and analytics unsubscribe!

Ark Tek Rex Taming, Stakeholder Presentation Powerpoint, Drub Crossword Clue, Mentions Crossword Clue, Non Dairy Hot Chocolate Mix, What Township Do I Live In By Zip Code, Trees For Coastal Areas,

Share:

Video

Be the first to comment “guardant health analysis”

(will not be shared)

"" was added to wishlist

WhatsApp chat